Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Decaens

Showing results (81-90 of 125) with videos related to

Pageof 13
Sort By:
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 12, 2006
Impact of UCSF criteria according to pre- and post-OLT tumor features: analysis of 479 patients listed for HCC with a short waiting timeThomas Decaens, Françoise Roudot-Thoraval, Solange Hadni-Bresson, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 2, 2025
A multicentric national phase II trial assessing TIslelizumab in monotherapy for patients with Hepatocellular Carcinoma Child-Pugh B and ALBI grade 1 or 2 liver function score: The UCGI 41 HESTIA TRIAL DESIGN AND PRELIMINARY SAFETY DataHéloïse Bourien, Xavier Adhoute, Boris Campillo-Gimenez, et al.
World Journal of Gastroenterology|December 5, 2006
Role of immunosuppression and tumor differentiation in predicting recurrence after liver transplantation for hepatocellular carcinoma: a multicenter study of 412 patientsThomas Decaens, Françoise Roudot-Thoraval, Solange Bresson-Hadni, et al.
British Journal of Clinical Pharmacology|April 1, 2020
Pharmacokinetics and safety of olaparib in patients with advanced solid tumours and mild or moderate hepatic impairmentChristian Rolfo, Nicolas Isambert, Antoine Italiano, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 24, 2005
Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinomaThomas Decaens, Françoise Roudot-Thoraval, Solange Bresson-Hadni, et al.
Hepatology (Baltimore, Md.)|February 5, 2016
Oncogenic driver genes and the inflammatory microenvironment dictate liver tumor phenotypeMatthias S Matter, Jens U Marquardt, Jesper B Andersen, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 14, 2017
Sorafenib vs surgical resection for hepatocellular carcinoma with macrovascular invasion: A propensity score analysisCharlotte E Costentin, Thomas Decaens, Alexis Laurent, et al.
Cancer|March 29, 2018
Hepatocellular carcinoma is diagnosed at a later stage in alcoholic patients: Results of a prospective, nationwide studyCharlotte E Costentin, Abbas Mourad, Pierre Lahmek, et al.
Hepatology (Baltimore, Md.)|July 13, 2022
Validation of the new 2021 EASL algorithm for the noninvasive diagnosis of advanced fibrosis in NAFLDClémence M Canivet, Charlotte Costentin, Katharina M Irvine, et al.
Biomarker Research|April 28, 2024
Plasma ALS and Gal-3BP differentiate early from advanced liver fibrosis in MASLD patientsDavid Pérez Compte, Lucas Etourneau, Anne-Marie Hesse, et al.
Pageof 13

Showing results (81-90 of 125) with videos related to

Sort By:
Pageof 13
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 12, 2006
Impact of UCSF criteria according to pre- and post-OLT tumor features: analysis of 479 patients listed for HCC with a short waiting timeThomas Decaens, Françoise Roudot-Thoraval, Solange Hadni-Bresson, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|August 2, 2025
A multicentric national phase II trial assessing TIslelizumab in monotherapy for patients with Hepatocellular Carcinoma Child-Pugh B and ALBI grade 1 or 2 liver function score: The UCGI 41 HESTIA TRIAL DESIGN AND PRELIMINARY SAFETY DataHéloïse Bourien, Xavier Adhoute, Boris Campillo-Gimenez, et al.
World Journal of Gastroenterology|December 5, 2006
Role of immunosuppression and tumor differentiation in predicting recurrence after liver transplantation for hepatocellular carcinoma: a multicenter study of 412 patientsThomas Decaens, Françoise Roudot-Thoraval, Solange Bresson-Hadni, et al.
British Journal of Clinical Pharmacology|April 1, 2020
Pharmacokinetics and safety of olaparib in patients with advanced solid tumours and mild or moderate hepatic impairmentChristian Rolfo, Nicolas Isambert, Antoine Italiano, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|June 24, 2005
Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinomaThomas Decaens, Françoise Roudot-Thoraval, Solange Bresson-Hadni, et al.
Hepatology (Baltimore, Md.)|February 5, 2016
Oncogenic driver genes and the inflammatory microenvironment dictate liver tumor phenotypeMatthias S Matter, Jens U Marquardt, Jesper B Andersen, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 14, 2017
Sorafenib vs surgical resection for hepatocellular carcinoma with macrovascular invasion: A propensity score analysisCharlotte E Costentin, Thomas Decaens, Alexis Laurent, et al.
Cancer|March 29, 2018
Hepatocellular carcinoma is diagnosed at a later stage in alcoholic patients: Results of a prospective, nationwide studyCharlotte E Costentin, Abbas Mourad, Pierre Lahmek, et al.
Hepatology (Baltimore, Md.)|July 13, 2022
Validation of the new 2021 EASL algorithm for the noninvasive diagnosis of advanced fibrosis in NAFLDClémence M Canivet, Charlotte Costentin, Katharina M Irvine, et al.
Biomarker Research|April 28, 2024
Plasma ALS and Gal-3BP differentiate early from advanced liver fibrosis in MASLD patientsDavid Pérez Compte, Lucas Etourneau, Anne-Marie Hesse, et al.
Pageof 13